With many new agents approved for the treatment of lung cancer, it is a tremendously exciting time for oncologists. But when treatments are so new and oncologists don’t yet fully understand their proper use or real risks and benefits for the patient sitting in front of them, determining the right thing to do is a challenge. Care pathways help, but cannot fully replace a physician’s judgment. And, of course, there is patient preference to consider in this new era of collaborative medical decision making.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
In his most recent ASCO Connection blog post, Cleveland Clinic oncologist Nathan Pennell, MD, PhD, discusses the complexities of moving new drugs into practice and encourages colleagues from all sides to continue the conversation.
Read the full article.